SCHEMBL1747121

SCHEMBL1747121

O=C(O)CCc1ccc(NC(=O)c2ccc(Oc3ccccc3)cc2)cc1

nearest known ligand 0.79

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 1/20 0.79
FFAR1 O14842 5/20 0.70
SRD5A2 P31213 1/20 0.70
PGR P06401 2/20 0.68
FFAR4 Q5NUL3 4/20 0.67
NR1H4 Q96RI1 3/20 0.64
TDP1 Q9NUW8 2/20 0.58
GNA15 P30679 1/20 0.58
PTGER3 P43115 1/20 0.58
MEN1 O00255 4/20 0.57
KMT2A Q03164 4/20 0.57
RXFP1 Q9HBX9 2/20 0.57
NPC1 O15118 1/20 0.57
RAB9A P51151 1/20 0.57
KDM4E B2RXH2 1/20 0.56
POLB P06746 1/20 0.56
DUSP3 P51452 1/20 0.56
PTPN5 P54829 1/20 0.56
PTPN11 Q06124 1/20 0.56
CTDSP1 Q9GZU7 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5488236 0.88 HDAC1 (1.00) HDAC1PGRTDP1MEN1KMT2A
SCHEMBL1232960 0.87 NR1H4 (0.71) HDAC1FFAR1FFAR4NR1H4TDP1
SCHEMBL22192258 0.85 PGR (0.93) HDAC1PGRNR1H4MEN1KMT2A
SCHEMBL1747191 0.85 HDAC1 (0.69) HDAC1SRD5A2PGRNR1H4TDP1
SCHEMBL1747309 0.84 RAB9A (0.78) FFAR1FFAR4NR1H4TDP1MEN1
SCHEMBL2774842 0.84 FFAR1 (1.00) FFAR1SRD5A2FFAR4TDP1GNA15
SCHEMBL22987223 0.84 HPGD (0.74) HDAC1FFAR1SRD5A2FFAR4NR1H4
SCHEMBL3142959 0.84 KDM4E (0.65) HDAC1FFAR1SRD5A2FFAR4NR1H4
SCHEMBL155094 0.83 PGR (0.72) HDAC1PGRNR1H4MEN1KMT2A
SCHEMBL17084712 0.83 PGR (0.72) HDAC1PGRNR1H4MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1559422-B1 RECEPTOR FUNCTION CONTROLLING AGENT TAKEDA PHARMACEUTICAL (JP) 2014-04-30 EP disclosed
EP-2385032-A1 GPR40 Receptor function regulator Takeda Pharmaceutical Company Limited (JP) 2011-11-09 EP disclosed
US-7960369-B2 Receptor function regulator TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2011-06-14 US disclosed
US-20090012093-A1 Receptor Function Regulator TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2009-01-08 US disclosed
EP-1559422-A1 RECEPTOR FUNCTION CONTROLLING AGENT Takeda Pharmaceutical Company Limited (JP) 2005-08-03 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090012093-A1 Receptor Function Regulator GPR119, GIPR, INSR HDAC1 2106/4885FFAR1 33/4885SRD5A2 1727/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.